
### [NCIT:C4342](http://purl.obolibrary.org/obo/NCIT_C4342)
**Label:** Intravascular Large B-Cell Lymphoma

**Subclasses:** [NCIT:C129602](http://purl.obolibrary.org/obo/NCIT_C129602) (Central Nervous System Intravascular Large B-Cell Lymphoma), [NCIT:C45214](http://purl.obolibrary.org/obo/NCIT_C45214) (Primary Cutaneous Intravascular Large B-Cell Lymphoma), [NCIT:C138025](http://purl.obolibrary.org/obo/NCIT_C138025) (Recurrent Intravascular Large B-Cell Lymphoma), [NCIT:C138026](http://purl.obolibrary.org/obo/NCIT_C138026) (Refractory Intravascular Large B-Cell Lymphoma), 

**Class expressions from DL-Learner:**

- Thing 54.38%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39712](http://purl.obolibrary.org/obo/NCIT_C39712) (KIT Gene Mutation))) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39711](http://purl.obolibrary.org/obo/NCIT_C39711) (C-KIT Tyrosine Kinase Protein Overexpression))) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39709](http://purl.obolibrary.org/obo/NCIT_C39709) (Confluent Sheets of Anaplastic T-Lymphocytes Present))) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39708](http://purl.obolibrary.org/obo/NCIT_C39708) (Cerebriform-Like Lymphocyte))) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C3970](http://purl.obolibrary.org/obo/NCIT_C3970) (Kidney Cyst))) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39695](http://purl.obolibrary.org/obo/NCIT_C39695) (Extranodal Disease))) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39692](http://purl.obolibrary.org/obo/NCIT_C39692) (Complete Spontaneous Regression))) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39691](http://purl.obolibrary.org/obo/NCIT_C39691) (Partial Spontaneous Regression))) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39690](http://purl.obolibrary.org/obo/NCIT_C39690) (Papular Lesion))) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39689](http://purl.obolibrary.org/obo/NCIT_C39689) (Multicentric Cutaneous Involvement))) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39688](http://purl.obolibrary.org/obo/NCIT_C39688) (Localized Skin Lesion))) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39687](http://purl.obolibrary.org/obo/NCIT_C39687) (Activated Mature Cytotoxic T-Lymphocyte))) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39686](http://purl.obolibrary.org/obo/NCIT_C39686) (Activated Skin-Homing T-Lymphocyte))) 37.02%


